Test of brain blood-flow control using near-infrared light
Part of Brain & nervous system clinical trials.
This study uses a non-invasive light test on the forehead to measure how your brain regulates its blood flow. It’s meant to help researchers understand brain circulation control in healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Be generally healthy (not having neurological disease)
- No past history of stroke or other cerebrovascular problems
- No history of major blood-vessel disease affecting the body
- Be able to take part as a healthy volunteer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a safe, non-invasive light-based technique called near-infrared spectroscopy (NIRS) to measure blood flow and oxygen in the brain. It aims to test a new monitoring device in healthy volunteers aged 20 to 40 to make sure it works correctly.
This study tests whether shining a special near-infrared light on the head can improve how well your brain works and how clearly you think. It is for healthy younger and older adults who want to help find new ways to support brain health.
This study looks at how the heart and brain control itself in otherwise healthy adults. You may be able to join if you’re an adult with normal heart rhythm and no nerve-system problems affecting control.
This trial tests if a simple, at-home arm cuff treatment (Remote Ischaemic Conditioning) can improve blood flow regulation in the brain of older adults. It may help understand how to protect brain health as we age.
This study looks at whether monitoring brain blood flow after a blocked artery is opened can help predict if the treatment will be successful. It may help doctors identify who might need additional help after stroke treatment.
This study measures blood flow in small areas of the brain to see if it can help detect cerebrovascular disease. It includes people recovering from a stroke and healthy volunteers, and may help improve future diagnosis.
Hear when a new Cerebral Autoregulation Mapping trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.